Roivant Sciences to Combine with Montes Archimedes Acquisition Corp. (MAAC) and Go Public as ROIV

Alvotech Merges with Oaktree Acquisition Corp. II and Lists on Nasdaq

June 15, 2022

Biotechnology

Alvotech completed a business combination with Oaktree Acquisition Corp. II and began trading on Nasdaq under the ticker ALVO, supported by an upsized $175 million PIPE from institutional and family-office investors. The transaction provides Alvotech with public-market access and growth capital to expand its global biosimilars development and manufacturing footprint.

Avant Technologies Proposes Acquisition of Ainnova Tech to Consolidate Vision AI JV

May 13, 2025

Healthcare Services

Avant Technologies has entered formal negotiations to acquire its joint-venture partner Ainnova Tech (operating through Ai-nova Acquisition Corp.), aiming to merge the businesses ahead of an FDA pre-submission meeting. The deal is intended to streamline regulatory coordination, speed clinical development and support U.S. market entry for the Vision AI clinical screening platform currently piloted across Latin America.

Datavant and Ciox Health Merge in $7.0B Deal to Create Largest Health Data Ecosystem

June 9, 2021

Data & Analytics

Datavant and Ciox Health signed a definitive agreement to merge in a transaction valued at $7.0 billion, creating a combined company to be named Datavant that will be the largest neutral health data ecosystem in the United States. The deal is supported by an investor group led by New Mountain Capital with significant new investment from Sixth Street and participation from Goldman Sachs Asset Management, Roivant Sciences and other strategic and financial investors; upon closing Pete McCabe will be CEO and Travis May will be President.

Riskonnect Acquires Ventiv Technology

January 11, 2024

Cloud & SaaS

Riskonnect has acquired Ventiv Technology to combine the two companies' risk, insurance and underwriting technology solutions into a unified integrated risk management platform. The deal, supported by Riskonnect's majority investor TA Associates, expands product capabilities (analytics, claims, billing, policy administration) and aims to accelerate global growth and customer value for the combined 2,500+ customers.

Ampersand Capital Partners Invests in iuvo BioScience

September 28, 2022

Healthcare Services

Ampersand Capital Partners has agreed to acquire a stake in iuvo BioScience, a Rochester-based specialty CRO that provides laboratory, preclinical, clinical development, and scientific consulting services. The investment will fund expansion of iuvo's integrated service portfolio and laboratory capacity and support an active inorganic (add-on) growth strategy; founders Ben Burton and Mary Richardson will remain in leadership roles and as shareholders.

Viveon Health Acquisition Corp. to Merge with Suneva Medical

January 12, 2022

Medical Devices

Suneva Medical, a San Diego–based regenerative aesthetics medical technology company, has entered into a definitive merger agreement with special purpose acquisition company Viveon Health Acquisition Corp. The transaction will combine Suneva with the public SPAC vehicle (NYSE American: VHAQ) to provide growth capital and public-market access for Suneva, with the combined company expected to trade on the NYSE under the symbol "RNEW."